Amgen Inc. Profile Avatar - Palmy Investing

Amgen Inc.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…
Drug Manufacturers - General
US, Thousand Oaks [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

FY Quarter Lobby Expense [in mil. $] Filing Report Time
2024 1 6 LDA-2 April 12, 2024, 2:48 p.m.
2022 4 6 LDA-2 Feb. 7, 2024, 3:50 p.m.
2023 4 6 LDA-2 Jan. 23, 2024, 2:37 a.m.
2023 4 6 LDA-2 Jan. 22, 2024, 9:07 p.m.
2023 4 6 LDA-2 Jan. 22, 2024, 8:41 p.m.
2023 4 5 LDA-2 Jan. 22, 2024, 7:23 p.m.
2023 4 6 LDA-2 Jan. 22, 2024, 3:58 p.m.
2023 4 5 LDA-2 Jan. 22, 2024, 1:55 p.m.
2023 4 5 LDA-2 Jan. 21, 2024, 8:16 p.m.
2023 4 5 LDA-2 Jan. 19, 2024, 2:43 p.m.
2023 4 5 LDA-2 Jan. 19, 2024, 12:58 p.m.
2023 4 5 LDA-2 Jan. 19, 2024, 1:49 a.m.
2023 4 6 LDA-2 Jan. 17, 2024, 8:47 p.m.
2023 4 6 LDA-2 Jan. 17, 2024, 6:31 p.m.
2023 4 6 LDA-2 Jan. 17, 2024, 12:10 a.m.
2023 4 6 LDA-2 Jan. 16, 2024, 3:26 p.m.
2023 4 6 LDA-2 Jan. 15, 2024, 7:13 p.m.
2023 4 5 LDA-2 Jan. 13, 2024, 12:36 a.m.
End of AMGN's Analysis
CIK: 318154 CUSIP: 031162100 ISIN: US0311621009 LEI: - UEI: -
Secondary Listings